top of page

GOP Senators File Bill To Block Biden Marijuana Rescheduling Effort Without Congressional Approval

  • Writer: Bob Marley
    Bob Marley
  • Sep 22, 2023
  • 3 min read

Two GOP senators, including the lead Republican sponsor of a marijuana banking bill, have officially filed new legislation to prevent federal agencies from rescheduling cannabis without tacit approval from Congress.

Sens. Cynthia Lummis (R-WY) and Steve Daines (R-MT) are sponsoring the Deferring Executive Authority (DEA) Act, which they briefly previewed this week in statements about the filing of the revised Secure and Fair Enforcement Regulation (SAFER) Banking Act.

The DEA Act, introduced on Thursday, would make it so any administrative proposal to transfer marijuana “between schedules” of the Controlled Substances Act (CSA)—as the U.S. Department of Health and Human Services (HHS) recently recommended to the Drug Enforcement Administration (DEA) as part of a review directed by President Joe Biden—must first be submitted to Congress for review. If lawmakers oppose it, they would then have 60 session days to pass a joint resolution to block its enactment.

“Congress makes the laws in this country, not D.C. bureaucrats,” Lummis said in a press release on Thursday. “The American people through their elected representatives in the Senate and House should have the final say on such a momentous change as the legalization of marijuana.”

That’s an interesting way to frame it, as polling has consistently showed that, unlike the bill sponsors, a strong and increasingly bipartisan majority of Americans support legalizing cannabis.

Lummis said in a separate interview with Ask a Pol’s Matt Laslo that she personally doesn’t want to see her state of Wyoming move to legalize—in part because she thinks “it just doesn’t smell good” and “stinks.”

“The Biden administration’s rush to reschedule marijuana without compelling scientific evidence appears to be political, not about what’s best for the American people,” Lummis said in her official statement, echoing points made by 14 of her GOP House and Senate colleagues who sent a letter to DEA last week, urging the administrator to “reject” HHS’s recommendation to simply move cannabis from Schedule I to Schedule III.

The senators’ bill would cover any marijuana scheduling action. While it’s currently in the strictest category under the CSA, it would also give Congress the authority to block proposed changes to move it back up in the schedule list in the future. The legislation specifically says lawmakers could intervene in “transferring marijuana between schedules” (emphasis added), so as a technical matter it’s unclear if that would include full descheduling (i.e. legalization) which would remove marijuana from the CSA altogether.

“While I disagreed with marijuana being legalized in Montana, the people spoke at the ballot box and I respect that decision,” Daines said. “However, I am firmly opposed to legalization or descheduling at the federal level without Congressional input.”

Lummis’s statement references a recent Congressional Research Service (CRS) report that assessed it was “likely” that DEA would abide by the HHS rescheduling recommendation, which was made following an 11-month scientific review stemming from Biden’s directive.

The senator’s office said moving cannabis to Schedule III as advised would, “in essence, legalize marijuana federally.” However, if marijuana is rescheduled, it would remain federally illegal except for medical use with a prescription from a doctor. And the Food and Drug Administration (FDA) generally does not approve holistic or plant-based medicine as drugs that can be prescribed.

Marijuana Moment is tracking more than 1,000 cannabis, psychedelics and drug policy bills in state legislatures and Congress this year. Patreon supporters pledging at least $25/month get access to our interactive maps, charts and hearing calendar so they don’t miss any developments.Learn more about our marijuana bill tracker and become a supporter on Patreon to get access.—

The legislation’s introduction comes during a week of heightened attention to federal cannabis policy, with a revised version of Daines’s bill to free up banking services for state-legal marijuana businesses—which Lummis is also cosponsoring—being filed on Wednesday as the Senate Banking Committee prepares for a markup next week.

Senate Majority Leader Chuck Schumer (D-NY) says he plans to attach amendments to the SAFER Banking Act to facilitate state-level cannabis expungements and preserve gun rights for medical cannabis patients when it reached the floor. Daines’s office has previously said that he’s amenable to the expungements add.

Also, House Democrats reintroduced a bill to federally legalize, tax and regulate marijuana on Wednesday, with provisions to expunge prior cannabis convictions. And in a campaign email to supporters, Schumer called on people to sign a petition to “demand” an end to federal marijuana prohibition.

Michigan Lawmaker Renews Push To Legalize Certain Psychedelic Plants And Fungi

Comments


Global SEO Keywords

marihuana, cannabis, cáñamo, CBD, aceite de CBD, bálsamo de CBD, marijuana, hemp, weed, CBD oil, CBD balm, canapa, erba, olio di CBD, balsamo CBD, chanvre, herbe, huile de CBD, baume CBD, Marihuana, Cannabis, Hanf, Gras, CBD Öl, CBD Balsam, maconha, cânhamo, erva, óleo de CBD, bálsamo CBD, hennep, wiet, CBD olie, CBD balsem, hampa, gräs, CBD olja, CBD balsam, hamp, græs, gress, CBD olje, hamppu, ruoho, CBD öljy, CBD balsami, konopie, konopie indyjskie, olej CBD, balsam CBD, konopí, CBD olej, CBD balzám, konope, CBD balzam, marihuána, kannabisz, kender, fű, CBD olaj, CBD balzsam, canabis, cânepă, iarbă, ulei CBD, марихуана, канабис, коноп, CBD масло, CBD балсам, μαριχουάνα, κάνναβη, χασίς, λάδι CBD, βάλσαμο CBD, kanabis, konoplja, trava, CBD ulje, CBD olje, kanapės, kanapės indinės, CBD aliejus, CBD balzamas, marihuāna, kaņepes, CBD eļļa, CBD balzams, marihuaana, kanep, CBD õli, CBD palsam, kannabis, qanneb, żejt CBD, balsam CBD, marijúna, hampur, CBD olía, CBD smyrsl

Disclaimer

Jacob Hooy CBD Lip Balm is free from parabens and artificial colorants and contains no toxins or heavy metals, supporting natural body care. Our products are not intended to diagnose, treat, cure, or prevent any disease, medical condition, or symptom. The information provided on this website is for informational purposes only and must not be considered medical advice, nor a substitute for professional diagnosis, treatment, or guidance provided by qualified physicians, healthcare professionals, or pharmaceutical specialists. Nothing on this website should be interpreted as a recommendation, prescription, or therapeutic claim.

Difresh Spain is an online retail store registered under IAE Group 652.3, specializing in the retail trade of perfumery, cosmetic products, and personal hygiene and care items. NIF: Y3526859-F. E-mail: info@cbdvending.eu - WhatsApp: +34662918154 - Factory adress: Calle Albardín 13, Nave B07, 50720, La cartuja baja, Zaragoza, España. All prices include VAT and free shipping across all European Union countries.

© 2026 - www.cbdvending.euPrivacy Policy

bottom of page